US · Healthcare · Biotechnology
EPS came in at 0.50 against a street estimate of -0.35 — a beat of 242.9%.
Analysts rate Xencor Inc a strong buy (12 buy, 2 hold, 0 sell out of 14) with an average price target of $41.58.
| Fund | Stake |
|---|---|
| BlackRock Inc | 18.36% |
| PRIMECAP Management Company | 13.69% |
| Bvf Inc | 9.59% |
| RTW INVESTMENTS, LLC | 9.12% |
| RA Capital Management, LLC | 7.09% |
| State Street Corp | 6.66% |
| Vanguard Capital Management, LLC | 4.41% |
| TCG Crossover Management, LLC | 3.30% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $116,520 thousand, up from $20,999 thousand in the third quarter of 2025. • Third-quarter net inco | 2026-11-04 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $116.5 million, compared with $21.0 million in the third quarter of 2025. • Net income attributabl | 2026-11-04 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Xencor presented updated Phase 1 results for XmAb819, an ENPP3 x CD3 bispecific antibody in advanced clear cell renal cell carcino | 2026-10-26 |
| Quarterly report · Q2 2026 XENCOR, INC. - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash position: $44.7 million in cash and equivalents as of June 30, 2026 (down from $54.1 mil | 2026-08-05 |
| Results announced · Q3 2026 XENCOR, INC. – Q2 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Cash position: $486.4 million as of June 30, 2026 (down from $610.8 million at D | 2026-08-05 |
| Results announced · Q3 2026 XENCOR, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Xencor settled a commercial dispute with Alexion Pharma International Operations Limited on July | 2026-07-29 |
| Shareholder vote results · Q2 2026 XENCOR, INC. - 2026 ANNUAL SHAREHOLDER MEETING SUMMARY HEADLINE NUMBERS • Annual shareholder meeting held June 16, 2026 • 63,939,410 shares present | 2026-06-18 |
| Quarterly report · Q1 2026 XENCOR, INC. — Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash Position: $14.2 million in cash and equivalents at March 31, 2026, down from $54.1 milli | 2026-05-06 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Xencor Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.